GENEVA, Switzerland – October 2019: The World Health Organization (WHO) evaluates the dependence-producing properties and potential harm to health of psychoactive substances. Recommendations from the WHO regarding international control under the International Drug Control Conventions are made to the Secretary-General of the United Nations and are subject to a vote by the United Nations Commission on Narcotic Drugs (CND).

Thirteen new psychoactive substances (NPS) will be considered for review at the 42nd meeting of the WHO Expert Committee on Drug Dependence (ECDD), including two benzodiazepines, five synthetic cannabinoids, three synthetic cathinones, two fentanyl analogues and one phenethylamine. The ECDD meeting will be held in Geneva from 21-25 October 2019. 

Benzodiazepines
Flualprazolam
Etizolam

Synthetic cannabinoids 
APINACA (AKB-48)
AB-FUBINACA
5F-AMB-PINACA (5F-AMB, 5F-MMB-PINACA)
5F-MDMB-PICA (5F-MDMB-2201)
4F-MDMB-BINACA (4F-ADB)

Synthetic cathinones
4-CMC (4-chloromethcathinone; clefedrone)
N-ethylhexedrone (NEH, Hexen, Ethyl-Hex)
Alpha-PHP (PV-7, α-pyrrolidinohexanophenone)

Fentanyl analogues 
Crotonylfentanyl
Valerylfentanyl

Phenethylamines
DOC (2,5-Dimethoxy-4-chloroamfetamine)

For more information, please see: